Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Increase in CD4+ T-Cell Count at the Time of HIV Diagnosis and Antiretroviral Treatment Initiation Among Persons With HIV in New York City.

Braunstein SL, Robertson MM, Myers J, Abraham B, Nash D.

J Infect Dis. 2016 Dec 1;214(11):1682-1686. Epub 2016 Oct 17.

PMID:
27892400
2.

Availability, Accessibility, and Price of Rapid HIV Self-Tests, New York City Pharmacies, Summer 2013.

Myers JE, El-Sadr Davis OY, Weinstein ER, Remch M, Edelstein A, Khawja A, Schillinger JA.

AIDS Behav. 2017 Feb;21(2):515-524. doi: 10.1007/s10461-016-1594-4.

PMID:
27804092
3.

Using HIV Viral Load From Surveillance to Estimate the Timing of Antiretroviral Therapy Initiation.

Braunstein SL, Robertson MM, Myers J, Nash D.

J Acquir Immune Defic Syndr. 2016 Oct 1;73(2):222-7. doi: 10.1097/QAI.0000000000001052.

4.

Human Immunodeficiency Virus Infection Newly Diagnosed at Autopsy in New York City, 2008-2012.

Ramaswamy C, Ellman TM, Myers J, Madsen A, Sepkowitz K, Shepard C.

Open Forum Infect Dis. 2015 Sep 30;2(4):ofv146. doi: 10.1093/ofid/ofv146. eCollection 2015 Dec.

5.

Implementation and Operational Research: CD4 Count Monitoring Frequency and Risk of CD4 Count Dropping Below 200 Cells Per Cubic Millimeter Among Stable HIV-Infected Patients in New York City, 2007-2013.

Myers JE, Xia Q, Torian LV, Irvine M, Harriman G, Sepkowitz KA, Shepard CW.

J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):e73-8. doi: 10.1097/QAI.0000000000000885.

6.

Expanded HIV testing coverage is associated with decreases in late HIV diagnoses.

Ransome Y, Terzian A, Addison D, Braunstein S, Myers J, Abraham B, Nash D.

AIDS. 2015 Jul 17;29(11):1369-78. doi: 10.1097/QAD.0000000000000684.

7.

Injectable agents for pre-exposure prophylaxis: lessons learned from contraception to inform HIV prevention.

Myers JE, Ellman TM, Westhoff C.

Curr Opin HIV AIDS. 2015 Jul;10(4):271-7. doi: 10.1097/COH.0000000000000166. Review.

PMID:
26049953
8.

HIV testing experience in New York City: offer of and willingness to test in the context of new legal support of routine testing.

Edelstein ZR, Myers JE, Cutler BH, Blum M, Muzzio D, Tsoi BW.

J Acquir Immune Defic Syndr. 2015 Jan 1;68 Suppl 1:S45-53. doi: 10.1097/QAI.0000000000000390.

PMID:
25545493
9.

Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York.

Kessler J, Myers JE, Nucifora KA, Mensah N, Toohey C, Khademi A, Cutler B, Braithwaite S.

AIDS. 2014 Nov 28;28(18):2683-91.

10.

Acceptability of home self-tests for HIV in New York City, 2006.

Myers JE, Bodach S, Cutler BH, Shepard CW, Philippou C, Branson BM.

Am J Public Health. 2014 Dec;104(12):e46-8. doi: 10.2105/AJPH.2014.302271. Epub 2014 Oct 16.

11.

Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program.

Irvine MK, Chamberlin SA, Robbins RS, Myers JE, Braunstein SL, Mitts BJ, Harriman GA, Laraque F, Nash D.

Clin Infect Dis. 2015 Jan 15;60(2):298-310. doi: 10.1093/cid/ciu783. Epub 2014 Oct 9. Erratum in: Clin Infect Dis. 2015 Jun 15;60(12):1879. Laraque, Fabienne [added].

12.

Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges.

McMahon JM, Myers JE, Kurth AE, Cohen SE, Mannheimer SB, Simmons J, Pouget ER, Trabold N, Haberer JE.

AIDS Patient Care STDS. 2014 Sep;28(9):462-74. doi: 10.1089/apc.2013.0302. Epub 2014 Jul 21. Review.

13.

The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.

Myers J, Wielage RC, Han B, Price K, Gahn J, Paget MA, Happich M.

BMC Musculoskelet Disord. 2014 Mar 11;15:76. doi: 10.1186/1471-2474-15-76. Review.

14.

Cost-effectiveness analyses of osteoarthritis oral therapies: a systematic review.

Wielage RC, Myers JA, Klein RW, Happich M.

Appl Health Econ Health Policy. 2013 Dec;11(6):593-618. doi: 10.1007/s40258-013-0061-x. Review.

PMID:
24214160
15.

Averting HIV infections in New York City: a modeling approach estimating the future impact of additional behavioral and biomedical HIV prevention strategies.

Kessler J, Myers JE, Nucifora KA, Mensah N, Kowalski A, Sweeney M, Toohey C, Khademi A, Shepard C, Cutler B, Braithwaite RS.

PLoS One. 2013 Sep 13;8(9):e73269. doi: 10.1371/journal.pone.0073269. eCollection 2013.

16.

Rapid HIV self-testing: long in coming but opportunities beckon.

Myers JE, El-Sadr WM, Zerbe A, Branson BM.

AIDS. 2013 Jul 17;27(11):1687-95. doi: 10.1097/QAD.0b013e32835fd7a0. Review.

PMID:
23807269
17.

Retraction: Functional characterization of the bladder cancer marker, BLCA-4.

Van Le TS, Myers J, Getzenberg RH, Konety BR, Barder T.

Clin Cancer Res. 2013 Jun 15;19(12):3327. doi: 10.1158/1078-0432.CCR-13-1145. Epub 2013 May 24. No abstract available.

18.

Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City.

Rucinski KB, Mensah NP, Sepkowitz KA, Cutler BH, Sweeney MM, Myers JE.

AIDS Behav. 2013 Jul;17(6):2180-4. doi: 10.1007/s10461-013-0443-y.

PMID:
23479003
19.

A pill for HIV prevention: déjà vu all over again?

Myers JE, Sepkowitz KA.

Clin Infect Dis. 2013 Jun;56(11):1604-12. doi: 10.1093/cid/cit085. Epub 2013 Feb 13. Review.

PMID:
23408681
20.

Blood and body fluid exposure related knowledge, attitude and practices of hospital based health care providers in United arab emirates.

Zaidi MA, Griffiths R, Beshyah SA, Myers J, Zaidi MA.

Saf Health Work. 2012 Sep;3(3):209-15. Epub 2012 Aug 30.

Supplemental Content

Loading ...
Support Center